Your browser doesn't support javascript.
loading
Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial.
Papazoglou, Despoina; Wang, Xin Victoria; Shanafelt, Tait D; Lesnick, Connie E; Ioannou, Nikolaos; De Rossi, Giulia; Herter, Sylvia; Bacac, Marina; Klein, Christian; Tallman, Martin S; Kay, Neil E; Ramsay, Alan G.
Afiliación
  • Papazoglou D; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
  • Wang XV; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Shanafelt TD; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA.
  • Lesnick CE; School of Medicine, Stanford University, Stanford, CA.
  • Ioannou N; Department of Immunology, Mayo Clinic, Rochester, MN.
  • De Rossi G; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.
  • Herter S; Institute of Ophthalmology, University College London, London, United Kingdom.
  • Bacac M; Discovery Oncology, Roche Innovation Center Zürich, Schlieren, Switzerland.
  • Klein C; Discovery Oncology, Roche Innovation Center Zürich, Schlieren, Switzerland.
  • Tallman MS; Discovery Oncology, Roche Innovation Center Zürich, Schlieren, Switzerland.
  • Kay NE; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ramsay AG; Department of Immunology, Mayo Clinic, Rochester, MN.
Blood ; 143(1): 57-63, 2024 01 04.
Article en En | MEDLINE | ID: mdl-37824808

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Límite: Humans Idioma: En Revista: Blood Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B Límite: Humans Idioma: En Revista: Blood Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido